AlphaYou
Overview
Key stats
Fundamentals Sep 12- Open
- $420.00
- 52-wk high
- $434.35
- High
- $426.39
- 52-wk low
- $270.87
- Low
- $413.09
- Prev close
- $416.54
- Mkt cap
- $90.81B
- P/E
- 18.5x
- Volume
- 1.32M
- Fwd P/E
- 14.3x
- Beta
- 0.70
- Div yield
- 1.65%
- P/S
- 0.5x
- P/B
- 2.0x
- Profit margin
- +2.5%
- Op margin
- +4.6%
- ROE
- +11.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders are trading both ways.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 20.6% above what analysts expected.
Earnings per share
$6.18 expected
Revenue
No comparable estimate
Reports Oct 20, 2026, in 37 days
EPS expected
$4.55 to $4.99
Revenue expected
11 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $50.71B | $49.75B | $50.18B | $50.47B |
| Cost of what it sold | $38.14B | $38.06B | $41.08B | $5.49B |
| Gross profit | $12.57B | $11.68B | $9.10B | $44.98B |
| What it spent | ||||
| Sales and admin | — | — | $6.33B | — |
| Other operating costs | $10.81B | $11.10B | $112.0M | $42.92B |
| Total operating expenses | $10.81B | $11.10B | $6.44B | $42.92B |
| What was left | ||||
| Operating profit | $1.76B | $581.0M | $2.66B | $2.06B |
| Interest on debt | $351.0M | $366.0M | $357.0M | $56.0M |
| Profit before tax | $1.41B | $215.0M | $2.30B | $1.94B |
| Tax | $219.0M | -$331.0M | $544.0M | $483.0M |
| Net profit | $1.19B | $547.0M | $1.76B | $1.46B |
| EBITDA | $2.14B | $987.0M | $2.77B | $2.10B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Should You Buy Elevance Health Stock For The Margin It Lost?
Leans bullishSep 11Cantor Fitzgerald reiterates Centene stock Overweight on Stars outlook By Investing.com
Leans bullishSep 11BofA Securities Adjusts Elevance Health Price Target to $480 From $460
Leans bullishSep 11Cantor Fitzgerald reiterates Centene stock Overweight on Stars outlook
Leans bullishSep 11Cantor Fitzgerald reiterates Molina Healthcare stock rating at neutral
NeutralSep 11Cantor Fitzgerald reiterates Neutral rating on Humana stock By Investing.com
NeutralSep 11Elevance Health Reaffirms 2026 Earnings and Cost Guidance
Leans bullishSep 11ELV Stock Steadies As Oppenheimer Meeting Nears
BullishSep 11
Macro
22 macro signals shaping ELV right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results